• Exchange: Nasdaq Dubai
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Hikma Pharmaceuticals PLC

+ Add to Watchlist


63.484 USD 0.0000.00%

As of 05:00:20 ET on 12/24/2014.

Snapshot for Hikma Pharmaceuticals PLC (HIK)

Open: 63.484 Day's Range: 63.484 - 63.484 Volume: 0
Previous Close: 63.484 52wk Range: 19.767 - 63.484 1-Yr Rtn: +220.77%

Stock Chart for HIK

No chart data available.
  • HIK:DU 63.484
  • 1D
  • 1M
  • 1Y
Interactive HIK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HIK

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 22.0737
Relative P/E vs. DFMGI -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 2.8760
Est. PEG Ratio 0.7675
Market Cap (M USD) 6,301.60
Shares Outstanding (M) 99.26
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.1300
Dividend Ex-Date 04/13/2011
5 Year Dividend Growth -
Next Earnings Announcement 03/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HIK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HIK

Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on developing, manufacturing, and marketing a range of both branded and non-branded generic and in-licensed pharmaceutical products. The Company's operations are conducted in the United States, the Middle East, and North Africa region, as well as Europe.

Said Sameeh Talib DarwazahChairman/CEOMazen Samih Taleb DarwazahVice Chairman/Pres & CEO:MENA
Khalid NabilsiChief Financial OfficerBassam KanaanChief Strategy & Corporate Dev Ofcr
More Company Profile & Key Executives for HIK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil